- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glabellar Crease in New Zealand
Total 2404 results
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedBreast CancerUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingBreast Carcinoma In Situ | Invasive Breast Carcinoma | Triple-Negative Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7United States, Canada, Puerto Rico
-
Millennium Pharmaceuticals, Inc.CompletedFallopian Tube Cancer | Breast Carcinoma | Ovarian Carcinoma | Peritoneal CancerUnited States
-
NYU Langone HealthTerminatedDuctal Carcinoma in SituUnited States
-
Hoffmann-La RocheCompletedBreast CancerUnited States
-
AstraZenecaRecruitingAdvanced Breast CancerChina, United States, Spain, Germany, Italy, Peru, United Kingdom, France, Brazil, Malaysia, Taiwan, Thailand, Hungary, Israel, Australia, Austria, Canada, Bulgaria, India, Japan, Poland, Czechia, Portugal, Hong Kong, Argentina, Puerto Rico, Chi... and more
-
Sysmex America, Inc.CompletedBreast Neoplasms | Breast DiseasesUnited States
-
SCRI Development Innovations, LLCCelgene CorporationCompletedBreast CancerUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Stage...United States, South Africa
-
Eli Lilly and CompanyTerminatedBreast CancerMexico, France, Australia, Argentina, South Africa
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaboratorsCompletedRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States, Canada, Switzerland
-
Novartis PharmaceuticalsRecruitingEarly Breast CancerChina, United States, Canada, Germany, Taiwan, Israel, Portugal, Hong Kong, Argentina, Australia, India, South Korea, Brazil, Turkey (Türkiye), Mexico, Puerto Rico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic Stage II Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Hormone Receptor... and other conditionsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Seagen Inc.Active, not recruitingAnatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC... and other conditionsUnited States, Canada, Puerto Rico
-
Angiochem IncCompletedBreast Cancer | Brain MetastasesUnited States
-
Memorial Sloan Kettering Cancer CenterWithdrawn
-
Hoffmann-La RocheTerminatedBreast CancerUnited States, Brazil, Australia, Canada, Japan, Korea, Republic of, Spain, United Kingdom
-
SuperSonic ImagineCompletedBreast NeoplasmsFrance, Germany, United States, Italy, United Kingdom
-
Eli Lilly and CompanyActive, not recruitingBreast CancerCanada, Australia, Japan, United States, Taiwan, Belgium, New Zealand, Italy, Spain, France, Israel, Netherlands, Germany, United Kingdom, Mexico, Greece, South Korea, Russia, Austria, Slovakia, Sweden, Turkey (Türkiye)
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)SuspendedAnatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | HER2-Negative Breast Carcinoma | Anatomic Stage 1 Breast Cancer AJCC v8 | Estrogen Receptor-Positive Breast CarcinomaUnited States, Puerto Rico
-
Syndax PharmaceuticalsRoche Pharma AGCompletedBreast CancerUnited States, Georgia
-
Cooler Heads Care Inc.WithdrawnBreast Cancer | Gynecologic Cancer | Alopecia | Chemotherapy-induced Alopecia | Hair LossUnited States
-
Tango Therapeutics, Inc.TerminatedBreast Cancer | Ovarian Cancer | Prostate Cancer | Pancreas Cancer | BRCA1 Mutation | BRCA-Mutated Ovarian Carcinoma | BRCA-Associated Breast Carcinoma | HRD Positive Advanced Ovarian CancerUnited States
-
National Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | Triple-Negative Breast Cancer | Serous Carcinoma CancerUnited States, Canada
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerCanada, Italy, Hungary, Taiwan, Turkey, Belgium, Germany, Spain, United States, Singapore, Australia, Korea, Republic of, Hong Kong, Thailand, Lebanon, Bulgaria, France, Russian Federation, Argentina, Brazil, Malaysia, Portugal, Col... and more
-
Roswell Park Cancer InstituteCompletedLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Eli Lilly and CompanyActive, not recruitingMetastatic Breast CancerSpain, Taiwan, United States, Italy, Czechia, Belgium, Brazil, Austria, Argentina, Germany, France, Mexico, Turkey (Türkiye), Russia
-
InSightecTerminatedBreast FibroadenomaUnited States, Japan
-
AstraZenecaCompletedMetastatic Breast CancerItaly, United Kingdom, Brazil, Czechia, Poland, United States, Spain, Bulgaria, France
-
Hoffmann-La RocheGenentech, Inc.CompletedBreast CancerItaly, Spain, Sweden, China, Hong Kong, Canada, South Africa, Ukraine, United States, United Kingdom, Russian Federation, Taiwan, Australia, Mexico, Turkey, Israel, Poland, Bulgaria, Germany, France, Netherlands, Norway, India, Hungary, Brazi... and more
-
Novartis PharmaceuticalsCompleted
-
ETOP IBCSG Partners FoundationAlliance for Clinical Trials in Oncology; Canadian Cancer Trials Group; Breast...Active, not recruitingEarly Breast CancerUnited States, France, Canada, Spain, Lebanon, Belgium, Denmark, Switzerland, Israel, Ireland, Japan, Italy, Austria, Australia, Greece, Hungary, Netherlands, Norway, Portugal, Serbia, Slovenia, South Korea
-
R-PharmCompletedMetastatic Breast CancerItaly, United Kingdom, United States, France, Spain
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast CarcinomaUnited States, Peru
-
AstraZenecaSWOG Clinical Trials Partnerships; Daiichi SankyoActive, not recruitingBreast CancerUnited States, Belgium, Canada, Denmark, Germany, Italy, Spain, United Kingdom, France, Japan, China, Taiwan, Brazil, Greece, Sweden, Puerto Rico, South Korea
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | Stage IV Breast CancerUnited States, Canada, Israel, Saudi Arabia, South Africa
-
German Breast GroupNovartisCompletedBreast Cancer | Hormone Receptor Positive TumorGermany
-
Novartis PharmaceuticalsCompleted
-
University of RochesterNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedBreast CancerChina, United States, South Africa, Russian Federation, Thailand, Bosnia and Herzegovina, Czech Republic, India, Poland
-
OBI Pharma, IncActive, not recruitingTriple Negative Breast CancerUnited States, China, Korea, Republic of, Taiwan, Russian Federation, Australia, Ukraine, South Africa, Brazil, Mexico, Hong Kong, Peru, Poland
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors, Excluding Breast CancerNetherlands, Switzerland, Denmark, United States
-
NSABP Foundation IncNational Cancer Institute (NCI); Eli Lilly and Company; AstraZenecaCompletedStudy of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal WomenBreast CancerUnited States, Canada, Puerto Rico
-
Roswell Park Cancer InstituteCompletedMelanoma | Soft Tissue Sarcoma | Breast Carcinoma | Lung Carcinoma | Malignant Neoplasm | Colon Carcinoma | Ovarian Neoplasm | Malignant Head and Neck Neoplasm | Adult Liver Carcinoma | Kidney NeoplasmUnited States
-
Gilead SciencesAlliance Foundation Trials, LLC.; NSABP Foundation Inc; GBG Forschungs GmbHRecruitingTriple Negative Breast CancerUnited States, Australia, Spain, United Kingdom, France, Germany, Belgium, Ireland, Italy, South Korea, Brazil
-
LeonaBioRecruitingMetastatic Breast CancerUnited States, Belgium, Israel, Spain, France, United Kingdom, China, Taiwan, Australia, Italy, Singapore, Canada, Germany, Poland, Romania, South Korea, Turkey (Türkiye)
-
Novartis PharmaceuticalsCompletedBreast CancerBelgium, France, Taiwan, Hungary, Germany, Singapore, Austria, Netherlands, Australia, Russian Federation, Spain, Canada, Israel, Japan, Korea, Republic of, Italy, United States, United Kingdom, Brazil, Hong Kong, Czech Republic, South...
-
CytomX TherapeuticsCompletedNeoplasms | Breast Cancer | Breast Neoplasms | Breast Neoplasms, Triple-Negative | Breast Neoplasms, Hormone Receptor Positive/HER2 NegativeUnited States, Spain, Korea, Republic of
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation